Qinli Wang - China Shineway Insider

China Shineway Pharmaceutical Group Limited -- Hong Kong Stock  

HKD 7.04  0.02  0.28%

Deputy General Manager

Mr. Wang Qinli serves as Deputy General Manager of China Shineway Pharmaceutical Group Ltd. He graduated from Henan Chinese Medical Institute with a bachelor degree in Chinese medicine in 1986. Prior to joining the Group Mr. Wang spent 10 years from 1986 to 1996 working in technology and new medicine research at a pharmaceutical manufacturer in Henan Province the PRC where he reached the post of Head of New Medicine Research and Head of Technology Department. Mr. Wang joined the Group in 1996 as manager of the research and development department and then was promoted to Deputy General Manager in 2003 responsible for overseeing the Groups production management and technology development.
Age: 51  Executive Since 2003      
86 311 8803 0066  http://www.shineway.com

Management Efficiency

The company has return on total asset (ROA) of 4.76 % which means that it generated profit of $4.76 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 8.98 % meaning that it generated $8.98 on every $100 dollars invested by stockholders.

Similar Executives

Entity Summary

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and trading of OTC Chinese pharmaceutical solutions in the People?s Republic of China and Hong Kong. China Shineway Pharmaceutical Group Limited (2877) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Shijiazhuang, and employs 4,110 people.

Did you try this?

Run Portfolio Optimization Now

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Hide  View All  NextLaunch Portfolio Optimization
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add China Shineway Pharmaceutical Group Limited to your portfolio

Top Management

China Shineway Pharm Leadership Team
Zhong Chen, Director
Zheng Wang, Director, Ph.D
Bun Lee, Executive
Mei Wong, Executive
Ching Lee, Director
Liutai Sun, Director
Luk Met, Executive
Yat Luk, Director
Guoan Luo, Director
King Hung, Director
Yunxia Xin, Director
Zhenjiang Li, Chairman
Li Cheng, Director
Chuanjun Yang, Executive
Huimin Li, Director
Qinli Wang, Executive

Stock Performance

China Shineway Performance Indicators